Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
03/25/2010 | US20100075901 Novel use of hiv nc protein |
03/25/2010 | US20100075898 N-terminal vdac variants and uses thereof |
03/25/2010 | US20100075869 siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1) |
03/25/2010 | US20100075434 Method for detecting target substance, and tag, DNA, vector, probe and detection kit for use therewith |
03/25/2010 | US20100075424 Methods and compositions for genetically engineering clostridia species |
03/25/2010 | US20100075423 Methods and compositions relating to polypeptides with rnase iii domains that mediate rna interference |
03/25/2010 | US20100075422 Transfection microarrays |
03/25/2010 | US20100075421 Efficient method for nuclear reprogramming |
03/25/2010 | US20100075420 Novel Gene Delivery Vectors for Human Mesenchymal Stem Cells |
03/25/2010 | US20100075412 T1r taste receptors and genes encoding same |
03/25/2010 | US20100075402 DNA coding for polypeptide fusion |
03/25/2010 | US20100075401 Minicircle dna vector preparations and methods of making and using the same |
03/25/2010 | US20100075397 Enzyme involved in biosynthesis of plant-protective phytochemical; catalyzes conversion of fatty acid hydroperoxide intermediates to divinyl ether fatty acids, bioactive oxylipins for biological pest control of phytopathogens such as late blight |
03/25/2010 | US20100075388 Plasmid, transformants and process for production of 3- carboxymuconolactone |
03/25/2010 | US20100075385 O-Methyltransferases of Tetrahydrobenzylisoquinoline Alkaloid Biosynthesis in Papaver Somniferum |
03/25/2010 | US20100075382 Ssb-polymerase fusion proteins |
03/25/2010 | US20100075380 Novel Lipase |
03/25/2010 | US20100075378 Moraxella catarrhalis basb115 polypeptides |
03/25/2010 | US20100075363 Recombinant Yeast Strains Expressing Tethered Cellulase Enzymes |
03/25/2010 | US20100075343 Novel peptides |
03/25/2010 | US20100075324 Processes for detecting toxic substances |
03/25/2010 | US20100075303 Methods for targetted mutagenesis in gram-positive bacteria |
03/25/2010 | US20100074995 Poplar transcription factors |
03/25/2010 | US20100074991 Novel oxidoreductases and uses thereof |
03/25/2010 | US20100074946 Process for preparing purified nucleic acid and the use thereof |
03/25/2010 | US20100074945 Mutated ras peptides for generation of cd8+ cytotoxic t lymphocytes |
03/25/2010 | US20100074919 Circovirus sequences associated with piglet weight loss disease (PWD) |
03/25/2010 | US20100074915 Chimeric influenza virus-like particles |
03/25/2010 | US20100074906 Antibodies Specific for Varicella Zoster Virus |
03/25/2010 | US20100074905 Methods for soluble zalpha11 cytokine receptors |
03/25/2010 | US20100074900 Prostaglandin e2 dual variable domain immunoglobulins and uses thereof |
03/25/2010 | DE69029370C5 Erythropoietin-Isoformen Erythropoietin isoforms |
03/25/2010 | DE102006021516B4 Gen-Konversionskonstrukt und Verfahren zur Vererbung von Genmobilität sowie Verwendung des Konstrukts Gene conversion construct and procedures for inheritance of Genmobilität and use of the construct |
03/25/2010 | CA2774710A1 Msp nanopores and related methods |
03/25/2010 | CA2774336A1 Genus-wide chlamydial peptide vaccine antigens |
03/25/2010 | CA2753338A1 Neutral nanotransporters |
03/25/2010 | CA2746527A1 Rna interference in skin indications |
03/25/2010 | CA2744523A1 Methods and vectors for display of molecules and displayed molecules and collections |
03/25/2010 | CA2743981A1 Reduced size self-delivering rnai compounds |
03/25/2010 | CA2738031A1 Methods and compositions for generating an immune response by inducing cd40 and pattern recognition receptor adapters |
03/25/2010 | CA2737748A1 Chinese hamster ovary cell lines |
03/25/2010 | CA2737544A1 Methods and compositions for degrading pectin |
03/25/2010 | CA2737507A1 Polypeptides substrates of lrrk2 and uses thereof |
03/25/2010 | CA2737429A1 Method for producing lactic acid from plant-derived raw material, and lactic-acid-producing bacterium |
03/25/2010 | CA2737428A1 Bacterium capable of producing lactic acid, and method for producing lactic acid |
03/25/2010 | CA2737405A1 Importation of a ribozyme into vegetable mitochondria by a pseudo-trna that can be aminoacylated by valine |
03/25/2010 | CA2737200A1 Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
03/25/2010 | CA2736975A1 Production and use of yeast having increased cellulose hydrolysis ability |
03/25/2010 | CA2736947A1 Novel bacillus thuringiensis gene with lepidopteran activity |
03/25/2010 | CA2736604A1 Rabies virus-based recombinant immunocontraceptive compositions and methods of use |
03/25/2010 | CA2736566A1 Method for producing an additive for the enzymatic degradation of mycotoxins and additive and use of the same |
03/25/2010 | CA2736438A1 Tyrosine kinase receptor tyro3 as a therapeutic target in the treatment of cancer |
03/25/2010 | CA2736205A1 Novel bacillus thuringiensis gene with lepidopteran activity |
03/25/2010 | CA2736181A1 Novel bacillus thuringiensis gene with coleopteran activity |
03/25/2010 | CA2735379A1 Mutant .delta.5 desaturases and their use in making polyunsaturated fatty acids |
03/25/2010 | CA2726845A1 Antibodies with altered binding to fcrn and methods of using same |
03/24/2010 | EP2166109A1 Method for producing alpha-L-aspartyl-L-phenylalanine-beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester |
03/24/2010 | EP2166107A1 Lentiviral vectors for the expression of shRNA |
03/24/2010 | EP2166106A2 Plants having improved growth characteristics and methods for making the same |
03/24/2010 | EP2166105A2 Plants having improved growth characteristics and method for making the same |
03/24/2010 | EP2166104A1 Method for isolation of transcription termination sequences |
03/24/2010 | EP2166103A1 Method for isolation of transcription termination sequences |
03/24/2010 | EP2166102A2 Expression enhancing intron sequences |
03/24/2010 | EP2166101A2 Expression enhancing intron sequences |
03/24/2010 | EP2166100A2 Expression enhancing intron sequences |
03/24/2010 | EP2166099A2 Expression enhancing intron sequences |
03/24/2010 | EP2166098A1 Constitutive expression cassettes for regulation of plant expression |
03/24/2010 | EP2166097A1 Constitutive expression cassettes for regulation of plant expression |
03/24/2010 | EP2166096A2 Moraxella (Branhamella) catarrhalis antigens |
03/24/2010 | EP2166095A2 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes in endothelial cells |
03/24/2010 | EP2166094A1 Methods for prolonging the health benefits triggered by a dietary restriction using a sphingosine kinase inhibitor |
03/24/2010 | EP2166093A1 Pharmaceutical composition for enzyme replacement therapy |
03/24/2010 | EP2166092A1 Detergent composition |
03/24/2010 | EP2166090A2 Method for production of polyunsaturated fatty acids in transgene organisms |
03/24/2010 | EP2166089A2 Method for production of polyunsaturated fatty acids in transgenic organisms |
03/24/2010 | EP2166088A1 Drug metabolism |
03/24/2010 | EP2166087A2 FAD4, FAD5, FAD5-2 et FAD6, fatty acid desaturase family members and uses thereof |
03/24/2010 | EP2166086A2 Plants having improved growth characteristics and methods for making the same |
03/24/2010 | EP2166084A1 Multipotent progenitor cell derived from adipose tissue |
03/24/2010 | EP2166071A2 Method for producing polyunsaturated fatty acids in transgenic organisms |
03/24/2010 | EP2166070A2 Method for producing polyunsaturated fatty acids in transgenic organisms |
03/24/2010 | EP2166069A2 Method for producing polyunsaturated fatty acids in transgenic organisms |
03/24/2010 | EP2166068A2 Method for producing polyunsaturated fatty acids in transgenic organisms |
03/24/2010 | EP2166067A2 Method for producing polyunsaturated fatty acids in transgenic organisms |
03/24/2010 | EP2166019A2 Immunisation against Chlamydia Pneumoniae |
03/24/2010 | EP2166017A1 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues |
03/24/2010 | EP2165714A1 Humanized antibodies recognizing the beta-amyloid peptide |
03/24/2010 | EP2165710A1 Tyrosine kinase receptor Tyro3 as a therapeutic target in the treatment of a bladder tumor |
03/24/2010 | EP2165199A1 Detection of cell surface binding molecules using a phage display blocking assay |
03/24/2010 | EP2164993A2 Methods for production and uses of multipotent cell populations, pluripotent cell populations, differentiated cell populations, and hiv-resistant cell populations |
03/24/2010 | EP2164972A1 Promoter |
03/24/2010 | EP2164971A2 Method for manufacturing active recombinant blood coagulation factor ix |
03/24/2010 | EP2164970A2 F. oxysporum f.sp. melonis race 1,2-resistant melons |
03/24/2010 | EP2164969A1 A method for sustainable transgene transcription |
03/24/2010 | EP2164968A2 Peg-pei copolymers for nucleic acid delivery |
03/24/2010 | EP2164967A2 Reduction of off-target rna interference toxicity |
03/24/2010 | EP2164966A2 Dsrna for treating viral infection |
03/24/2010 | EP2164965A2 A primary micro rna expression cassette |
03/24/2010 | EP2164964A1 Dehydrated chitosan nanoparticles |
03/24/2010 | EP2164962A1 Butenedioic acid or derivatives thereof for treating a biological sample |